ADT impacts mood of patients with prostate cancer, as perceived by partners

the ONA take:

Androgen deprivation therapy negative impacts the mood of patients with prostate cancer and those negative effects are concurrently observed by their partners, according to a new study published online ahead of print in the journal Psycho-Oncology.

For the study, researchers from Mount Allison University in Sackville, Canada, and the University of British Columbia in Vancouver, Canada, sought to assess the relationship between androgen deprivation therapy and the mood of patients with prostate cancer and their partners.

Researchers enrolled 295 patients and 84 partners. Participants completed an online survey evaluating the patients' current mood and mood prior to therapy, relationship adjustment, and sexual function. Results were compared with that of men who received non-hormonal treatments. Results showed that 82 patients currently treated with androgen deprivation therapy reported worsened mood compared with the 213 not on hormonal therapy. Researchers found that the 42 partners of patients on hormonal therapy reported declines in the patient's mood, but to a greater extent that the patient.

"The psychological changes related to ADT can impact relationships and affect the quality of life of both PCa patients and partners," the authors conclude. "Patients and their partners are likely to benefit from being well informed about the psychological effects of androgen deprivation on men beginning ADT."

ADT impacts mood of patients with prostate cancer, as perceived by partners
Androgen deprivation therapy negative impacts the mood of patients with prostate cancer.
Researchers assessed the relationship between of androgen deprivation therapy and the mood of prostate cancer patients and partners of prostate cancer patients.
READ FULL ARTICLE From Wiley Online Library
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs